Phase IIAndrogen Modulator
Compound 61591
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061591
Risk Class
HIGH
Last Audit
Apr 25, 2108
Research Abstract
Androgen Modulator candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61591 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in phase ii with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061591 with updates logged 2108-04-25.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61591Androgen Modulator Program 61591
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061591
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61591